A breast cancer patient in England with HER2-low metastatic breast cancer has expressed overwhelming relief after learning that the life-extending drug Enhertu is now available on the NHS, providing patients an average of nearly seven more months to live. The drug has been accessible in Scotland and 26 other European countries since at least 2023, while Wales is expected to soon approve its use, though Northern…
'I can get more time': Breast cancer patient finds out she can get life extending drug (this article)2 articles from BBC on this story
